Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dedicated

The Difficulties of Living with Depression Don’t End with the Illness Itself

This month Mary Assimakopoulos examines some of the insights gathered while surveying 2,000 patients suffering with this often misunderstood mental illness.

Inizio

Patient Power: Too Much of a Good Thing?

Mary Assimakopoulos, reveals findings from the company’s Therapy Watch market research data, investigating patient behaviour in Crohn’s Disease and discusses how pharma can benefit from improved patient understanding

Inizio

- PMLiVE

GSK and Pfizer combine melanoma drugs in new trial

Will investigate effects of adding palbociclib to Mekinist

Sanofi reception

Sanofi moves closer to arthritis drug filing

Reports positive late-stage results for sarilumab

- PMLiVE

Rare disease strategy for the UK launched

Aims to improve understanding and boost research

- PMLiVE

Roche CMO joins Google health venture Calico

Hal Barron among four new appointments

- PMLiVE

Blue Latitude boosts senior management team

Elisa del Galdo joins as head of customer experience

- PMLiVE

Gaming to educate doctors

E-learning CME needs to be “fun”

EU flag

Telling times for medical devices in EU

What does the European regulatory review herald for the sector?

Daiichi Sankyo logo

Daiichi Sankyo says meets targets in AF study

Edoxaban on course to add to next generation anticoagulants to replace warfarin

- PMLiVE

GSK cashes in its stake in Africa’s Aspen

Sells 28.2 million shares

- PMLiVE

FDA turns down Forest/Gedeon Richter’s antipsychotic

US regulator wants more information for cariprazine

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links